Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for BDMS.BK and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for BDMS.BK and 80,000+ other tickers.
See exactly how BDMS.BK's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for BDMS.BK and 80,000+ other tickers.
Bangkok Dusit Medical Services Public Company Limited (BDMS) functions as a prominent healthcare conglomerate, with its subsidiaries primarily engaged in operating and owning hospitals. The company oversees a portfolio of six major hospital networks, specifically the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. Beyond providing extensive medical treatment, BDMS also offers holistic clinical wellness programs. Its diversified business interests extend to hospitality, managing hotels and restaurants, as…
No recent news available.